Published in J Gastroenterol on July 05, 2016
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med (2006) 10.63
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol (2010) 4.55
Management of cirrhosis and ascites. N Engl J Med (2004) 4.31
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology (2003) 3.00
The Good Clinical Practice guideline: a bronze standard for clinical research. Lancet (2005) 2.81
Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research. J Clin Pathol (2008) 2.77
Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology (2013) 2.33
The 50th anniversary of the Declaration of Helsinki: progress but many remaining challenges. JAMA (2013) 2.16
Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial. Hepatol Res (2013) 1.19
Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema. J Int Med Res (2013) 1.09
The pharmacokinetics and pharmacodynamics of tolvaptan in patients with liver cirrhosis with insufficient response to conventional diuretics: a multicentre, double-blind, parallel-group, phase III study. J Int Med Res (2012) 1.04
Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol (2011) 0.99
Correlation between changes in bodyweight and changes in ascites volume in liver cirrhosis patients with hepatic edema in short-term diuretic therapy. Hepatol Res (2013) 0.98
Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan. J Gastroenterol (2015) 0.97
Management of ascites in cirrhosis. J Gastroenterol Hepatol (2012) 0.93
Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol (2010) 0.93
Tolvaptan for the treatment of liver cirrhosis oedema. Expert Rev Gastroenterol Hepatol (2014) 0.90
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Blood Urea Nitrogen/Creatinine Ratio and Response to Tolvaptan in Patients with Decompensated Heart Failure: A Retrospective Analysis. Am J Cardiovasc Drugs (2015) 0.81
Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol (2016) 0.77
Histological and Transcriptomic Analysis of Adult Japanese Medaka Sampled Onboard the International Space Station. PLoS One (2015) 0.77
Endoscopic retrieval of a button battery using the tip of a magnetic tube. Dig Endosc (2019) 0.75
Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function. PLoS One (2022) 0.75
Inhibition of sodium-glucose cotransporter 2 ameliorated renal injury in a novel medaka model of nonalcoholic steatohepatitis-related kidney disease. FEBS Open Bio (2019) 0.75
A rare case of Paneth cell-rich depressed adenoma in the terminal ileum. Gastrointest Endosc (2019) 0.75
Prevention of esophageal stricture after endoscopic submucosal dissection using RNA-based silencing of carbohydrate sulfotransferase 15 in a porcine model. Endoscopy (2017) 0.75
Efficacy of gelatin hydrogels incorporating triamcinolone acetonide for prevention of fibrosis in a mouse model. Regen Ther (2019) 0.75